Navigation Links
GSK Charitable Support Valued at $564 Million in 2007
Date:3/19/2008

LONDON, March 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today reported its 2007 global giving to charitable initiatives totaled $564 million, equivalent to almost 4% of pre-tax profits for the company (with the FTSE 100 average around 1%). Donations of albendazole treatments for the company's flagship program to eliminate Lymphatic Filariasis (commonly known as elephantiasis) were valued at $29 million, bringing the total number of treatments given since GSK made its commitment 10 years ago to almost 750 million.

Commenting on the figures JP Garnier, CEO of GlaxoSmithKline said: "I want GSK to be part of global healthcare solutions, not only through our medicines and vaccines, but also through our public health programs and work with communities. This is embedded in our business, not just an 'add on'; whether it is eliminating LF, supporting HIV communities, fighting malaria, or preventing diabetes. Our partnerships offer more than a helping hand; they are transforming the lives and prospects of people all over the world."

GSK supports health and education programs in more than 100 countries through donations of medicines and through long-term partnerships that provide financial and practical support. The $564 million investment includes product donations valued at $448 million, cash giving of $82 million and other in-kind donations, such as equipment, valued at $6 million. The costs to administer and deliver these programs were $28 million.

The $448 million of product donations included:

-- A continuation of the Lymphatic Filariasis elimination program which

since 1998 has seen the donation of almost 750 million albendazole

treatments by GSK. This program, now in the tent
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Virginia G. Piper Charitable Trust and Flinn Foundation launch
2. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
3. Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
4. Online Charitable Holiday Giving: Making a Difference with the Gifts You Give
5. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
6. China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues
7. MDS Designates Cancer its Major Charitable Cause on World Cancer Day
8. HIV therapy in pregnancy-data support WHO recommendations
9. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
10. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
11. Family-based treatment more effective than supportive psychotherapy in treating bulimia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... and Market Analysis to 2023” focuses on the ... commercial opportunities in the colorectal cancer market. Stivarga ... treatment of colon or rectal cancer. Boehringer Ingelheim ... inhibitor, for the treatment of refractory CRC in ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... Thompson HealthDay Reporter WEDNESDAY, ... complex chronic illnesses can receive effective, less expensive care from ... access to a team of dedicated health care professionals, a ... seriously ill and need either hospitalization or a trip to ... medical home clinic at the University of Texas in Houston ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... LUGANO, SWITZERLAND, June 4, 2008 Finbarr Cotter, M.D., ... Science at Barts and The London School of Medicine, ... in CLL by GCS-100: a Phase 2 Study" at ... The promising interim results from this ongoing clinical trial ...
... Will be Held in Berlin ... from 22 to 24 September, BERLIN, June ... disablement? Experts from,throughout the world will address this question at the 4th ... Berlin,Congress Centre from 22 to 24 September 2008. The IFDM will be ...
... Offerings, MOUNTAINSIDE, N.J., June 4 L&M ... the opening of a new full-service Midwest office ... as Vice President, Client Services., These enhancements ... and better meet the needs of their growing ...
... M. Redstone to Accept Award At June 9 ... ... Global Business,Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) announced today that,it will ... Excellence at its June 9th annual,celebration. The GBC, an organization of more ...
... Scientists at Karolinska Institutet in Sweden and Miami University have ... in a way hitherto unknown. The discovery can eventually be ... aim of the project was to find out how the ... known for a long time that glucose is regulated with ...
... Monitoring extreme weather, such as periods of high ... intensity of infectious diseases like cryptosporidiosis, an intestinal disease ... researchers have created a model that takes into account ... people who will fall ill during an outbreak. With ...
Cached Medicine News:Health News:Clinical study shows biological and clinical activity in relapsed leukemia patients 2Health News:Clinical study shows biological and clinical activity in relapsed leukemia patients 3Health News:Retaining Employees' Capacity For Work Following Sickness 2Health News:L&M Healthcare Communications LLC Expands With Hiring of New Executive Staff & Opening of Midwest Office 2Health News:Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy 2Health News:Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy 3Health News:Discovery of new signal pathway important to diabetes research 2Health News:Weather, stomach bugs and climate change: Refining the model 2
(Date:12/24/2014)... 2014  Novastem, a leader in regenerative medicine, ... its study for ischemic stroke at Clinica Santa ... strokes account for 87 percent of all stroke ... the study, entitled "Internal Research Protocol in Combination ... Cells and Intrathecal Administration of Neural Stem Cells ...
(Date:12/24/2014)... Pa. , Dec. 24, 2014  Commonwealth Cornerstone Group ... Markets Tax Credits transaction on Tuesday to help fund the ... Network (PHN) in Sharon . ... in Pennsylvania . It is the largest ... with more than 150 people on staff. Currently, ...
(Date:12/24/2014)... N.Y. , Dec. 24, 2014 Kinex ... dosed with KX2-361 at Roswell Park Cancer Institute. ... small molecule drug that has shown potent inhibitory activity ... including those that are resistant to Temozolomide (T98G), the ... glioma. In a well-established brain tumor mouse model, KX2-361 ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... OMER ) today announced that its exclusive license to ... been amended to include addiction and compulsive disorders in the ... Company,s discovery of a previously unknown link between PDE7 and ... it also is the first to link PDE7 to any ...
... BRUNSWICK, N.J. and LEIDEN, Netherlands, Feb. 22, 2011 Johnson ... (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) ... offer for Crucell N.V. (Crucell) and has declared the offer ... center for vaccines within the Johnson & Johnson pharmaceuticals group. ...
Cached Medicine Technology:Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo 2Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo 3Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo 4Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 2Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 3Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 4Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 5Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 6Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 7Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional 8
... Radianse active-RFID-tags can be ... For example, that a device ... complete or that a patient ... Every message from an ID-tag ...
... labels are carefully crafted with the ... antennas. SATO Techno THERM RFID labels ... ensure optimum performance in your SATO ... encoders are available in HF and ...
Featuring a secure and tamper-evident adhesive closure, computer-generated Smart ScanBand can be simultaneously printed with bar code information and programmed with RFID information....
... enables immediate infant location ... door locking and abduction ... match infants to their ... switching, secure their safety ...
Medicine Products: